HUMAN DISEASE MODELED by pd27Tg; sd2Tg; zf169Tg; zf71Tg
No data available

GENE EXPRESSION
Gene expression in pd27Tg; sd2Tg; zf169Tg; zf71Tg

PHENOTYPE
Phenotype in pd27Tg; sd2Tg; zf169Tg; zf71Tg

Phenotype	Conditions	Figures
head kidney has fewer parts of type hematopoietic stem cell, abnormal	gamma ray	Fig. 3 from Cortes et al., 2016
head kidney has fewer parts of type hematopoietic stem cell, ameliorated	gamma ray, chemical treatment by environment: calcitriol	Fig. 3 from Cortes et al., 2016
hematopoietic stem cell increased amount, abnormal	chemical treatment by environment: calcipotriol	Fig. 3 from Cortes et al., 2016
hematopoietic stem cell proliferation increased occurrence, abnormal	chemical treatment by environment: calcidiol	Fig. 2  from Cortes et al., 2016
hematopoietic stem cell proliferation increased occurrence, abnormal	chemical treatment by environment: calcitriol	Fig. 2 ,  Fig. 5  from Cortes et al., 2016
hematopoietic stem cell proliferation increased occurrence, abnormal	chemical treatment by environment: calcipotriol	Fig. 2  from Cortes et al., 2016
ventral wall of dorsal aorta has extra parts of type hematopoietic multipotent progenitor cell, abnormal	chemical treatment by environment: calcipotriol	Fig. 2  from Cortes et al., 2016
ventral wall of dorsal aorta has extra parts of type hematopoietic multipotent progenitor cell, abnormal	chemical treatment by environment: calcidiol	Fig. 2  from Cortes et al., 2016
ventral wall of dorsal aorta has extra parts of type hematopoietic multipotent progenitor cell, abnormal	chemical treatment by environment: calcitriol	Fig. 2 ,  Fig. 5  from Cortes et al., 2016
ventral wall of dorsal aorta has normal numbers of parts of type hematopoietic multipotent progenitor cell, normal	standard conditions	Fig. 1 ,  Fig. 5  from Cortes et al., 2016
whole organism dead, abnormal	gamma ray, chemical treatment by environment: calcitriol	text only from Cortes et al., 2016